Literature DB >> 29239710

Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.

Koichiro Yasaka1, Hiroyuki Akai1, Akira Kunimatsu1, Osamu Abe1, Shigeru Kiryu1.   

Abstract

Purpose To investigate the performance of a deep convolutional neural network (DCNN) model in the staging of liver fibrosis using gadoxetic acid-enhanced hepatobiliary phase magnetic resonance (MR) imaging. Materials and Methods This retrospective study included patients for whom input data (hepatobiliary phase MR images, static magnetic field of the imaging unit, and hepatitis B and C virus testing results available, either positive or negative) and reference standard data (liver fibrosis stage evaluated from biopsy or surgical specimens obtained within 6 months of the MR examinations) were available were assigned to the training (534 patients) or the test (100 patients) group. For the training group (54, 53, 81, 113, and 233 patients with fibrosis stages F0, F1, F2, F3, and F4, respectively; mean patient age, 67.4 ± 9.7 years; 388 men and 146 women), MR images with three different section levels were augmented 90-fold (rotated, parallel-shifted, brightness-changed and contrast-changed images were generated; a total of 144 180 images). Supervised training was performed by using the DCNN model to minimize the difference between the output data (fibrosis score obtained through deep learning [FDL score]) and liver fibrosis stage. The performance of the DCNN model was evaluated in the test group (10, 10, 15, 20, and 45 patients with fibrosis stages F0, F1, F2, F3, and F4, respectively; mean patient age, 66.8 years ± 10.7; 71 male patients and 29 female patients) with receiver operating characteristic (ROC) analyses. Results The FDL score was correlated significantly with fibrosis stage (Spearman rank correlation coefficient: 0.63; P < .001). Fibrosis stages F4, F3, and F2 were diagnosed with areas under the ROC curve of 0.84, 0.84, and 0.85, respectively. Conclusion The DCNN model exhibited a high diagnostic performance in the staging of liver fibrosis. © RSNA, 2017 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29239710     DOI: 10.1148/radiol.2017171928

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  44 in total

1.  Progress in non-invasive detection of liver fibrosis.

Authors:  Chengxi Li; Rentao Li; Wei Zhang
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

Review 2.  Technical and clinical overview of deep learning in radiology.

Authors:  Daiju Ueda; Akitoshi Shimazaki; Yukio Miki
Journal:  Jpn J Radiol       Date:  2018-12-01       Impact factor: 2.374

3.  Liver shape analysis using partial least squares regression-based statistical shape model: application for understanding and staging of liver fibrosis.

Authors:  Mazen Soufi; Yoshito Otake; Masatoshi Hori; Kazuya Moriguchi; Yasuharu Imai; Yoshiyuki Sawai; Takashi Ota; Noriyuki Tomiyama; Yoshinobu Sato
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-11-08       Impact factor: 2.924

Review 4.  Deep learning with convolutional neural network in radiology.

Authors:  Koichiro Yasaka; Hiroyuki Akai; Akira Kunimatsu; Shigeru Kiryu; Osamu Abe
Journal:  Jpn J Radiol       Date:  2018-03-01       Impact factor: 2.374

Review 5.  CT and MR perfusion techniques to assess diffuse liver disease.

Authors:  Maxime Ronot; Benjamin Leporq; Bernard E Van Beers; Valérie Vilgrain
Journal:  Abdom Radiol (NY)       Date:  2020-11

6.  Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network.

Authors:  Jeong Hyun Lee; Ijin Joo; Tae Wook Kang; Yong Han Paik; Dong Hyun Sinn; Sang Yun Ha; Kyunga Kim; Choonghwan Choi; Gunwoo Lee; Jonghyon Yi; Won-Chul Bang
Journal:  Eur Radiol       Date:  2019-09-02       Impact factor: 5.315

7.  A deep residual learning network for predicting lung adenocarcinoma manifesting as ground-glass nodule on CT images.

Authors:  Jing Gong; Jiyu Liu; Wen Hao; Shengdong Nie; Bin Zheng; Shengping Wang; Weijun Peng
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

8.  Deep learning for staging liver fibrosis on CT: a pilot study.

Authors:  Koichiro Yasaka; Hiroyuki Akai; Akira Kunimatsu; Osamu Abe; Shigeru Kiryu
Journal:  Eur Radiol       Date:  2018-05-14       Impact factor: 5.315

9.  A radiomics-based model to classify the etiology of liver cirrhosis using gadoxetic acid-enhanced MRI.

Authors:  Aboelyazid Elkilany; Uli Fehrenbach; Timo Alexander Auer; Tobias Müller; Wenzel Schöning; Bernd Hamm; Dominik Geisel
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

10.  Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Subin Heo; Dong Wook Kim; Sang Hyun Choi; Seong Woo Kim; Jong Keon Jang
Journal:  Eur Radiol       Date:  2022-01-19       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.